Business Services Industry

Antigenics CEO to Present at JPMorgan's 24th Annual Healthcare Conference

Business Wire, Jan 5, 2006

NEW YORK -- Antigenics Inc. (NASDAQ: AGEN) today announced that Garo H. Armen, PhD, the company's chairman and CEO, will present at JPMorgan's 24th Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco at 8:30 a.m. PT on Thursday, January 12.

Dr. Armen will provide an overview of the company and its priority development programs, including Oncophage(R) (vitespen; formerly HSPPC-96) therapeutic cancer vaccine; AG-707 therapeutic vaccine for genital herpes infection; Aroplatin liposomal platinum agent for cancers; and AU-801, a novel preclinical application of Antigenics' proprietary heat shock protein technology as a treatment for autoimmune disorders.

The audio portion of the presentation will be webcast live and available subsequently by replay on the JPMorgan website at http://www.mapdigital.com/jpmorgan/healthcare06/. The replay of the webcast will begin approximately 24 hours after the live presentation and will be available for 30 days. Following the presentation, the audio replay and presentation slides will be available for seven days on the Antigenics website, www.antigenics.com.

Antigenics is a biotechnology company working to develop treatments for cancers, infectious diseases and autoimmune disorders.

COPYRIGHT 2006 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale

Most Recent Business Articles

Most Recent Business Publications

Most Popular Business Articles

Most Popular Business Publications